APA (7th ed.) Citation

Horwitz, S. M. (2018). Activity of the PI3K-{delta},{gamma} inhibitor duvelisib in a phase 1 trial and preclinical models of T-cell lymphoma. American Society of Hematology (ASH).

Chicago Style (17th ed.) Citation

Horwitz, S. M. Activity of the PI3K-{delta},{gamma} Inhibitor Duvelisib in a Phase 1 Trial and Preclinical Models of T-cell Lymphoma. American Society of Hematology (ASH), 2018.

MLA (9th ed.) Citation

Horwitz, S. M. Activity of the PI3K-{delta},{gamma} Inhibitor Duvelisib in a Phase 1 Trial and Preclinical Models of T-cell Lymphoma. American Society of Hematology (ASH), 2018.

Warning: These citations may not always be 100% accurate.